The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas-Reference-Cited by-同舟云学术

The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas

Published:2017-05-09 Issue:31 Volume:8 Page:51164-51176
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chen Daishi¹²,Rauh Manfred³,Buchfelder Michael¹,Eyupoglu Ilker Y.¹,Savaskan Nicolai¹⁴

Affiliation:

1. Translational Cell Biology and Neurooncology laboratory at the Department of Neurosurgery, Universitätsklinikum Erlangen (UKER), Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany

2. Department of Otolaryngology-Head and Neck Surgery, Chinese PLA General Hospital, Beijing, China

3. Department of Pediatrics and Adolescent Medicine, Universitätsklinikum Erlangen (UKER), Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany

4. BiMECON Ent., Berlin, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ATF family members as therapeutic targets in cancer: From mechanisms to pharmacological interventions;Pharmacological Research;2024-10

2. Ferroptosis in glioma therapy: advancements in sensitizing strategies and the complex tumor-promoting roles;Brain Research;2024-10

3. Suppression of Glioblastoma Proliferation by Inducing Oxidative Stress via Modulation of TXNDC12 Expression;International Journal of Cancer Management;2024-09-14

4. Gene regulatory network topology governs resistance and treatment escape in glioma stem-like cells;Science Advances;2024-06-07

5. Dihydroartemisinin induces ferroptosis in T cell acute lymphoblastic leukemia cells by downregulating SLC7A11 and activating the ATF4‑CHOP signaling pathway;Oncology Letters;2024-05-24